Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare nerve, joint, and migraine recovery logs from real patients—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Migraine, Pain & Joints Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Migraine, Pain & Joints Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Neurology, Stroke & Movement Disorders

Neurology, Stroke & Movement Disorders (78 Condition Guides)

Stroke recovery, Parkinson disease, multiple sclerosis, cranial nerve disorders, and movement conditions.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Neurology, Stroke & Movement Disorders Guides (78)

Clear Filter × Page 2 of 3

Extrapyramidal and movement disorder

Extrapyramidal and movement disorder (ICD-10-CM G25.9) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Facial myokymia

Facial myokymia (ICD-10-CM G51.4) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Friedreich's ataxia

Friedreich's ataxia (ICD-10-CM G11.11) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Geniculate ganglionitis

Designated in federal medical registries as G51.1, Geniculate ganglionitis falls under Brain & Neurology management, where neurorehabilitation tracking [Geniculate ganglionitis G51.1] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Giant Cell Arteritis

Giant cell arteritis is a disorder that causes inflammation of your arteries, usually in the scalp, neck, and arms. It narrows the arteries, which keeps blood from flowing well. Giant cell arteritis often occurs with another disorder called polymyalgia rheumatica. Both are more common in women than in men. They almost always affect people over the age of 50. Early symptoms of giant cell arteritis resemble the flu: fatigue, loss of appetite, and fever.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Gliosis

Gliosis—coded clinically as G62.9 across Brain & Neurology guidelines—combines CSF/autoimmune antibody panels in Gliosis (G62.9: when indicated) with structured follow-up of HbA1c & Blood in Gliosis (G62.9: Pressure Neuro-Targets) (BP < 120/75 mmHg; HbA1c < 5.7% (G62.9)).

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Heat stroke

Also called: Stroke

Heat stroke (ICD-10-CM T67.01XA) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Hemorrhagic Stroke

Also called: Intracerebral Hemorrhage • Subarachnoid Hemorrhage

A stroke happens when there is a loss of blood flow to part of the brain. Your brain cells cannot get the oxygen and nutrients they need from blood, and they start to die within a few minutes. This can cause lasting brain damage, long-term disability, or even death. There are two main types of strokes, ischemic and hemorrhagic. A hemorrhagic stroke is less common but often more severe. It occurs when a blood vessel in the brain bursts, causing bleeding (hemorrhage) in or around the brain. This bleeding increases pressure inside the skull and damages brain tissue. Within minutes, brain cells begin to die.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Hereditary and idiopathic neuropathy

Hereditary and idiopathic neuropathy (ICD-10-CM G60.9) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Hereditary motor and sensory neuropathy

Hereditary motor and sensory neuropathy (ICD-10-CM G60.0) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Horner's syndrome

Horner's syndrome (ICD-10-CM G90.2) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Idiopathic progressive neuropathy

Idiopathic progressive neuropathy (ICD-10-CM G60.3) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Ischemic Stroke

Also called: Embolic Stroke • Thrombotic stroke

A stroke happens when there is a loss of blood flow to part of the brain. Your brain cells cannot get the oxygen and nutrients they need from blood, and they start to die within a few minutes. This can cause lasting brain damage, long-term disability, or even death. There are two main types of strokes, ischemic and hemorrhagic. Ischemic stroke is the more common type. An ischemic stroke happens when a blood clot blocks a blood vessel in the brain. Quick treatment can save a life and improve the chances of recovery. What causes an ischemic stroke? Ischemic strokes are usually caused by one or more of the following: A blood clot.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Melkersson's syndrome

Melkersson's syndrome (ICD-10-CM G51.2) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Meningitis - aseptic

Meningitis - aseptic (ICD-10-CM G03.0) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Motion Sickness

Also called: Airsickness • Carsickness • Seasickness

Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Anyone can get it, but it is more common in children, pregnant women, and people taking certain medicines. Motion sickness can start suddenly, with a queasy feeling and cold sweats. It can then lead to dizziness and nausea and vomiting. Your brain senses movement by getting signals from your inner ears, eyes, muscles, and joints. When it gets signals that do not match, you can get motion sickness. For example, if you are reading on your phone while riding a bus, your eyes are focused on something that is not moving, but your inner ear senses motion.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Movement Disorders

Movement disorders are neurologic conditions that cause problems with movement, such as: Increased movement that can be voluntary (intentional) or involuntary (unintended) Decreased or slow voluntary movement There are many different movement disorders. Some of the more common types include: Ataxia, the loss of muscle coordination Dystonia, in which involuntary contractions of your muscles cause twisting and repetitive movements. The movements can be painful. Huntington's disease, an inherited disease that causes nerve cells in certain parts of the brain to waste away. This includes the nerve cells that help to control voluntary movement.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Multiple Sclerosis

Multiple sclerosis (MS) is a disease that affects your brain and spinal cord, also called the central nervous system. MS damages myelin, the protective coating around your nerve cells. Myelin helps nerves send messages quickly. When it's damaged, messages between your brain and body slow down or get blocked. This leads to MS symptoms. What are the types of multiple sclerosis? Not everyone with MS has the same experience. MS is grouped into types based on how the disease changes over time. Types of MS include: Relapsing-remitting MS. The most common type.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Myoclonus

Myoclonus (ICD-10-CM G25.3) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Neurologic Diseases

Also called: Nervous system diseases

The brain, spinal cord, and nerves make up the nervous system. Together they control all the workings of the body. When something goes wrong with a part of your nervous system, you can have trouble moving, speaking, swallowing, breathing, or learning. You can also have problems with your memory, senses, or mood. There are more than 600 neurologic diseases.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Neuropathy in association with hereditary ataxia

Neuropathy in association with hereditary ataxia (ICD-10-CM G60.2) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Olivopontocerebellar atrophy

Also called: Atrophy • Atrophic • Atrophies

Olivopontocerebellar atrophy (ICD-10-CM G23.8) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Paralysis

Also called: Hemiplegia • Palsy • Paraplegia

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia. Most paralysis is due to strokes or injuries such as spinal cord injury or a broken neck.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Parkinson's Disease

Also called: Paralysis agitans • Shaking palsy

Parkinson's disease (PD) is a type of movement disorder. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. Sometimes it is genetic, but most cases do not seem to run in families. Exposure to chemicals in the environment might play a role. Symptoms begin gradually, often on one side of the body. Later they affect both sides. They include: Trembling of hands, arms, legs, jaw and face Stiffness of the arms, legs and trunk Slowness of movement Poor balance and coordination As symptoms get worse, people with the disease may have trouble walking, talking, or doing simple tasks.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Pneumocephalus

Pneumocephalus (ICD-10-CM G93.89) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Polyneuropathy

Polyneuropathy (ICD-10-CM G62.9) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Polyneuropathy due to other toxic agents

Polyneuropathy due to other toxic agents (ICD-10-CM G62.2) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Pseudobulbar palsy

Pseudobulbar palsy (ICD-10-CM G12.29) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Radiation-induced polyneuropathy

Radiation-induced polyneuropathy (ICD-10-CM G62.82) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Refsum's disease

Refsum's disease—coded clinically as G60.1 across Brain & Neurology guidelines—combines sensorimotor neurologic examination [Refsum's disease G60.1] with structured follow-up of Carotid Duplex / in Refsum's disease (G60.1: Cerebral Perfusion) (No hemodynamically significant stenosis (G60.1)).

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Restless Legs

Also called: RLS • Willis-Ekbom Disease • Limb

Restless legs syndrome (RLS) causes a powerful urge to move your legs. Your legs become uncomfortable when you are lying down or sitting. Some people describe it as a creeping, crawling, tingling, or burning sensation. Moving makes your legs feel better, but not for long. RLS can make it hard to fall asleep and stay asleep. In most cases, there is no known cause for RLS. In other cases, RLS is caused by a disease or condition, such as anemia or pregnancy. Some medicines can also cause temporary RLS. Caffeine, tobacco, and alcohol may make symptoms worse. Lifestyle changes, such as regular sleep habits, relaxation techniques, and moderate exercise during the day can help.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Restless leg syndrome

Also called: Akathisia

Restless leg syndrome (ICD-10-CM G25.89) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Restless legs syndrome

Restless legs syndrome (ICD-10-CM G25.81) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Stiff-man syndrome

Stiff-man syndrome (ICD-10-CM G25.82) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Stroke Rehabilitation

Stroke rehabilitation is a program for people who have had a stroke. A stroke happens when there is a loss of blood flow to part of the brain. Your brain cells cannot get the oxygen and nutrients they need from blood, and they start to die within a few minutes. This can cause lasting brain damage, long-term disability, or even death. Stroke rehabilitation can help you relearn skills you lost because of the damage. It can help with movement, speech, strength, and daily living skills. The goal is to help you become as independent as possible.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Subdural empyema

Subdural empyema (ICD-10-CM G06.2) is evaluated within Neurology, Stroke & Movement Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Neurology, Stroke & Movement Disorders on dotMD.com?

dotMD.com maps Neurology, Stroke & Movement Disorders against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Neurology, Stroke & Movement Disorders visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee